Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.
SKYE
7 quarters
Position history for JPMorgan Chase & Co.'s holdings in Skye Bioscience, Inc.
Yes. JPMorgan Chase holds 66 shares of SKYE (Skye Bioscience), worth $44, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. JPMorgan Chase has held SKYE since Q4 2025, across 3 quarterly 13F filings.
Current Value
$44
Current Shares
66
Total Value Change
-$44,382
Total Shares Change
-11,296
Quarter-by-Quarter History
Other major holders of SKYE: BlackRock Finance, Inc., Janus Henderson Group Ltd., Baker Bros. Advisors LP